124 related articles for article (PubMed ID: 8982070)
1. Reexamining interaction of the SH2 domains of SYP and GAP with insulin and IGF-1 receptors in the two-hybrid system.
Lamothe B; Bucchini D; Jami J; Joshi RL
Gene; 1996 Dec; 182(1-2):77-80. PubMed ID: 8982070
[TBL] [Abstract][Full Text] [Related]
2. Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein.
Seely BL; Reichart DR; Staubs PA; Jhun BH; Hsu D; Maegawa H; Milarski KL; Saltiel AR; Olefsky JM
J Biol Chem; 1995 Aug; 270(32):19151-7. PubMed ID: 7642582
[TBL] [Abstract][Full Text] [Related]
3. Interaction of p85 subunit of PI 3-kinase with insulin and IGF-1 receptors analysed by using the two-hybrid system.
Lamothe B; Bucchini D; Jami J; Joshi RL
FEBS Lett; 1995 Oct; 373(1):51-5. PubMed ID: 7589433
[TBL] [Abstract][Full Text] [Related]
4. Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP.
Staubs PA; Reichart DR; Saltiel AR; Milarski KL; Maegawa H; Berhanu P; Olefsky JM; Seely BL
J Biol Chem; 1994 Nov; 269(44):27186-92. PubMed ID: 7525547
[TBL] [Abstract][Full Text] [Related]
5. Interaction of SH2-containing protein tyrosine phosphatase 2 with the insulin receptor and the insulin-like growth factor-I receptor: studies of the domains involved using the yeast two-hybrid system.
Rocchi S; Tartare-Deckert S; Sawka-Verhelle D; Gamha A; van Obberghen E
Endocrinology; 1996 Nov; 137(11):4944-52. PubMed ID: 8895367
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.
Richards RG; Walker MP; Sebastian J; DiAugustine RP
J Biol Chem; 1998 May; 273(19):11962-9. PubMed ID: 9565625
[TBL] [Abstract][Full Text] [Related]
7. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner.
Zhang-Sun G; Yang C; Viallet J; Feng G; Bergeron JJ; Posner BI
Endocrinology; 1996 Jul; 137(7):2649-58. PubMed ID: 8770882
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF- I) receptor: comparative study using the yeast two-hybrid system.
Tartare-Deckert S; Murdaca J; Sawka-Verhelle D; Holt KH; Pessin JE; Van Obberghen E
Endocrinology; 1996 Mar; 137(3):1019-24. PubMed ID: 8603569
[TBL] [Abstract][Full Text] [Related]
9. Characterization and cloning of a 58/53-kDa substrate of the insulin receptor tyrosine kinase.
Yeh TC; Ogawa W; Danielsen AG; Roth RA
J Biol Chem; 1996 Feb; 271(6):2921-8. PubMed ID: 8621681
[TBL] [Abstract][Full Text] [Related]
10. Potential involvement of FRS2 in insulin signaling.
Delahaye L; Rocchi S; Van Obberghen E
Endocrinology; 2000 Feb; 141(2):621-8. PubMed ID: 10650943
[TBL] [Abstract][Full Text] [Related]
11. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
Band CJ; Posner BI; Dumas V; Contreres JO
Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3'-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase.
Cengel KA; Kason RE; Freund GG
Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):397-404. PubMed ID: 9761740
[TBL] [Abstract][Full Text] [Related]
13. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp.
Kuhné MR; Pawson T; Lienhard GE; Feng GS
J Biol Chem; 1993 Jun; 268(16):11479-81. PubMed ID: 8505282
[TBL] [Abstract][Full Text] [Related]
14. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor.
Maile LA; Clemmons DR
Endocrinology; 2002 Nov; 143(11):4259-64. PubMed ID: 12399420
[TBL] [Abstract][Full Text] [Related]
15. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4.
Marengère LE; Waterhouse P; Duncan GS; Mittrücker HW; Feng GS; Mak TW
Science; 1996 May; 272(5265):1170-3. PubMed ID: 8638161
[TBL] [Abstract][Full Text] [Related]
16. Interaction of wild type and dominant-negative p55PIK regulatory subunit of phosphatidylinositol 3-kinase with insulin-like growth factor-1 signaling proteins.
Mothe I; Delahaye L; Filloux C; Pons S; White MF; Van Obberghen E
Mol Endocrinol; 1997 Dec; 11(13):1911-23. PubMed ID: 9415396
[TBL] [Abstract][Full Text] [Related]
17. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
[TBL] [Abstract][Full Text] [Related]
18. Identification of a putative Syp substrate, the PDGF beta receptor.
Klinghoffer RA; Kazlauskas A
J Biol Chem; 1995 Sep; 270(38):22208-17. PubMed ID: 7545675
[TBL] [Abstract][Full Text] [Related]
19. Receptor-binding, tyrosine phosphorylation and chromosome localization of the mouse SH2-containing phosphotyrosine phosphatase Syp.
Feng GS; Shen R; Heng HH; Tsui LC; Kazlauskas A; Pawson T
Oncogene; 1994 Jun; 9(6):1545-50. PubMed ID: 8183548
[TBL] [Abstract][Full Text] [Related]
20. Prolonged vs transient roles for early cell cycle signaling components.
Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
